Repaglinide

Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. The mechanism of action of repaglinide involves promoting insulin release from β-islet cells of the pancreas; like other antidiabetic drugs, a main side effect concern is hypoglycemia. It is sold by Novo Nordisk under the name of Prandin in the United States, GlucoNorm in Canada, Surepost in Japan, Repaglinide in Egypt by EIPICO, and NovoNorm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma.

Product Compare (0)
Prandin 0.5mg (Generic)
Prandin 0.5mg (Generic)
$0.39
WHAT IS THIS MEDICATION FOR? Prandin 0.5mg (Generic) is a meglitinide antidiabetic, prescribed f..
Prandin 1mg (Generic)
Prandin 1mg (Generic)
$0.59
WHAT IS THIS MEDICATION FOR? Prandin 1mg (Generic) is a meglitinide antidiabetic, prescribed for..
Prandin 2mg (Generic)
Prandin 2mg (Generic)
$0.79
WHAT IS THIS MEDICATION FOR? Prandin 2mg (Generic) is a meglitinide antidiabetic, prescribed for..
Showing 1 to 3 of 3 (1 Pages)